Abstract
The value of risk reduction in CNS drug development: use of expected net present value (eNPV) as a model
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have